Vietnam’s in vitro diagnostics market is forecast to grow from US$349.3 million in 2025 to US$503.6 million by 2034. Rising demand for advanced testing, molecular diagnostics and point-of-care solutions is creating opportunities across laboratory equipment, reagents, automation and connected diagnostic technologies.
Vietnam’s laboratory freezer market is estimated at US$20–30 million in 2025, with potential to reach US$30–45 million by 2030. Growth in pharmaceutical manufacturing, biotechnology, diagnostics and life sciences research is driving demand for ultra-low-temperature storage, intelligent monitoring and advanced cold-chain solutions.
Vietnam’s next-generation sequencing (NGS) market is forecast to grow from US$60.4 million in 2025 to US$222.5 million by 2036, driven by rising demand for precision medicine, cancer diagnostics, reproductive genetics and molecular testing. Growth is creating opportunities across sequencing platforms, reagents, consumables, bioinformatics and genomic data analysis.
Vietnam’s point-of-care diagnostics market is forecast to double from US$230.5 million in 2025 to US$465.4 million by 2034, driven by demand for faster, more accessible testing. Advances in molecular diagnostics, portable testing platforms and connected technologies are creating opportunities across rapid tests, instruments, reagents and digital diagnostics.
Vietnam’s LIMS market is expanding rapidly as laboratories adopt digital systems to improve sample tracking, workflow automation, data integrity and compliance. The market is estimated to grow from US$2.04 billion in 2025 to US$4.86 billion by 2031, driven by healthcare modernisation, pharmaceutical manufacturing, diagnostics, biotechnology and laboratory automation.
Vietnam’s liquid handling systems market is expanding as pharmaceutical R&D, biotechnology, genomics and laboratory automation accelerate. Valued at approximately US$15 million in 2025, the market is forecast to reach around US$23 million by 2033. Demand is being driven by higher-throughput testing, molecular diagnostics, drug discovery and the modernisation of healthcare and research laboratories.
Vietnam’s clinical trial ecosystem is expanding, creating growing demand for central laboratory services, CROs, biomarker testing and clinical research support. The broader clinical trial services market is estimated at US$240–300 million in 2025, while clinical laboratory services are valued at US$1.1 billion. Growth is being driven by multinational trials, regulatory reform, precision medicine, genomics and increased pharmaceutical and biotechnology investment.
Vietnam’s PCR market is expanding as real-time and digital PCR support infectious disease testing, oncology, genetic research and precision medicine, with digital PCR creating new opportunities in advanced diagnostics, liquid biopsy and life-science research.
Vietnam’s radiotherapy market is expanding as rising cancer incidence, capacity constraints and ageing treatment systems drive investment in advanced radiation technologies, precision oncology and connected cancer-care infrastructure.
Vietnam’s microscopy market is expanding as investment in life sciences, diagnostics, pharmaceutical research and advanced manufacturing drives demand for digital, automated and AI-enabled imaging technologies.
Vietnam’s laboratory automation market is expanding as diagnostics, pharmaceuticals, biotechnology and genomics drive demand for smart, connected laboratories with automated workflows, robotics, informatics and AI-enabled technologies.
Vietnam’s haematology diagnostics market is expanding as rising testing volumes and healthcare investment drive demand for automated analysers, advanced blood testing, digital morphology and recurring laboratory consumables.
Vietnam’s laboratory mixers market is expanding alongside growth in pharmaceuticals, biotechnology, diagnostics and life-science research, driving demand for reliable, precise and increasingly automated laboratory equipment.
Vietnam’s laboratory glassware market is expanding as pharmaceutical research, diagnostics, biotechnology and testing infrastructure grow, driving demand for reliable, reusable and precision laboratory products.
Vietnam’s mass spectrometry market is expanding as pharmaceutical, biotechnology, diagnostic and laboratory sectors invest in advanced analytical technologies. Valued at US$20.44 million in 2024, it is forecast to reach US$38.57 million by 2032. Growing demand across pharmaceutical R&D, proteomics, clinical diagnostics, food safety and environmental testing is creating opportunities for advanced instruments, software, consumables and laboratory services.
Vietnam’s laboratory automation market is expanding as hospitals, diagnostic centres, pharmaceutical companies and research institutions invest in higher-capacity, more efficient testing workflows. Valued at US$30.4 million in 2025, it is forecast to reach US$50.6 million by 2034. Growing adoption of robotics, liquid handling, LIMS, AI and automated sample processing is creating opportunities across clinical diagnostics, pharmaceuticals, biotechnology, genomics and research.
Vietnam’s multiomics market is emerging as investment in biotechnology, genomics and precision medicine accelerates. Estimated at US$20–30 million in 2025, it could reach US$45–65 million by 2030. Growing adoption of genomics, proteomics, transcriptomics, single-cell analysis and AI-powered bioinformatics is creating opportunities across pharmaceutical R&D, diagnostics, biotechnology, research and specialist analytical services.
Vietnam’s Research Use Only (RUO) recombinant protein market is emerging alongside growth in biotechnology, pharmaceutical R&D and advanced life sciences. Estimated at US$3–4 million in 2025, it could reach US$5–6 million by 2030. Rising demand for cytokines, growth factors, recombinant antigens and enzymes is creating opportunities across drug discovery, cell culture, oncology, immunology, organoid research and regenerative medicine.
Vietnam’s urinalysis market is expanding as investment in laboratory diagnostics, preventive health and chronic-disease management increases testing demand. Estimated at US$25–35 million in 2025, it could reach US$40–55 million by 2030. Growing adoption of automated analysers, urine sediment systems, point-of-care testing and digital workflows is creating opportunities across IVD equipment, reagents, consumables and laboratory technologies.
Vietnam’s immunohistochemistry market is emerging as cancer diagnostics and precision oncology capabilities advance. Estimated at US$8–12 million in 2025, it could reach US$13–20 million by 2030. Growing adoption of biomarker testing, personalised cancer treatment, digital pathology and laboratory automation is creating opportunities across IHC reagents, automated staining, pathology imaging, companion diagnostics and molecular testing.
Vietnam’s IVD quality control market is developing alongside the expansion and modernisation of diagnostic laboratories. Estimated at US$2–4 million in 2025, it could reach US$3–6 million by 2030. Growing adoption of molecular diagnostics, laboratory accreditation, automation and point-of-care testing is driving demand for quality-control materials, third-party controls, proficiency testing and digital QC solutions.
Vietnam’s contrast media market is expanding alongside investment in advanced diagnostic imaging. Estimated at US$45–65 million in 2025, it could reach US$65–90 million by 2030. Growing demand for CT, MRI, angiography and contrast-enhanced imaging, driven by rising chronic disease and healthcare modernisation, is creating opportunities across contrast agents, injectors, imaging equipment, AI and diagnostic technologies.
Vietnam’s microscopy market is expanding as investment in life sciences, diagnostics, pharmaceutical R&D and advanced manufacturing drives demand for sophisticated imaging technologies. Valued at US$279 million in 2025, it is projected to reach US$394 million by 2032. Growing adoption of digital microscopy, AI-powered image analysis and automation is creating opportunities across diagnostics, biotechnology, pharmaceuticals, research and high-tech manufacturing.
Vietnam’s liquid biopsy market is emerging as cancer diagnostics and precision medicine capabilities advance. Estimated at US$25–40 million in 2025, it could reach US$55–85 million by 2030. Growing adoption of ctDNA, NGS, PCR and non-invasive cancer testing is creating opportunities across early detection, treatment monitoring, companion diagnostics, genomics, laboratory automation and precision oncology.
Vietnam’s CAR T-cell therapy market is emerging as oncology and precision medicine capabilities advance. Valued at US$0.91 million in 2024, it is projected to reach US$2.32 million by 2032. Growing investment in cell and gene therapies, biotechnology, clinical research and advanced laboratory infrastructure is creating opportunities across biopharmaceuticals, specialised oncology, cell manufacturing and life sciences technologies.
Vietnam's mass spectrometry market is growing through pharmaceutical research, diagnostics, biotechnology and advanced laboratory innovation.
Vietnam's cancer biomarkers market is expanding through precision oncology, genomics, liquid biopsy and personalised cancer diagnostics.
Vietnam's healthcare analytics market is expanding rapidly, driven by AI, digitalisation, cloud adoption and data-driven healthcare.
Vietnam's NGS market is expanding rapidly, driven by precision medicine, oncology, genomics, biotechnology and advancing molecular diagnostics.
Vietnam's laboratory automation market is expanding through digitalisation, robotics, AI, diagnostics, and life sciences innovation.
Vietnam's IVD market is growing through advanced diagnostics, laboratory modernisation, precision medicine, and healthcare investment.
Vietnam's flow cytometry market is advancing through precision medicine, clinical diagnostics, biotechnology research, and laboratory innovation.
Vietnam's point-of-care diagnostics market is expanding through rapid testing, healthcare decentralisation, molecular diagnostics, and digital innovation.
Vietnam's oligonucleotide synthesis market is advancing through genomics, molecular diagnostics, precision medicine, and biotechnology innovation.
Vietnam's IVD quality control market is growing through laboratory accreditation, molecular diagnostics, automation, and quality assurance
Vietnam's point-of-care molecular diagnostics market is expanding through rapid testing, decentralised care, AI, and advanced diagnostics
Vietnam's IVD market is growing through laboratory modernisation, molecular diagnostics, healthcare investment, and precision medicine adoption.
Vietnam's cancer biomarkers market is expanding rapidly, driven by precision oncology, molecular diagnostics, and personalised cancer care.
Vietnam's mass spectrometry market is growing through expanding life sciences, precision medicine, pharmaceutical research, and diagnostics.
Vietnam's nuclear medicine market is expanding through oncology investment, molecular imaging, precision diagnostics, and targeted radionuclide therapies.
Vietnam's expanding oncology infrastructure and rising cancer burden are accelerating demand for advanced radiotherapy technologies nationwide.
Vietnam's laboratory automation market is growing through healthcare digitalisation, AI adoption, and expanding diagnostics and life sciences.
Vietnam's oligonucleotide synthesis market is advancing through genomics, molecular diagnostics, precision medicine, and biotechnology innovation.
